{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:38:26Z","timestamp":1757612306849,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"DOI":"10.7759\/cureus.91582","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T08:56:17Z","timestamp":1756976177000},"source":"Crossref","is-referenced-by-count":0,"title":["Proteinase 3-Antineutrophil Cytoplasmic Antibody (PR3-ANCA)-Associated Vasculitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Angela","family":"Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich B","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, et al.. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024, 83:30-47. 10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1070","article-title":"ANCA associated vasculitis","volume":"369","author":"Hunter RW","year":"2020","unstructured":"Hunter RW, Welsh N, Farrah TE, Gallacher PJ, Dhaun N. ANCA associated vasculitis. BMJ. 2020, 369:m1070. 10.1136\/bmj.m1070","journal-title":"BMJ"},{"key":"ref4","unstructured":"Understanding AAV. (2025). https.\/\/understandaav.com\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching AR","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, et al.. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020, 6:71. 10.1038\/s41572-020-0204-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson PC","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al.. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2022, 81:309-14. 10.1136\/annrheumdis-2021-221794","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson JC","year":"2022","unstructured":"Robson JC, Grayson PC, Ponte C, et al.. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022, 81:315-20. 10.1136\/annrheumdis-2021-221795","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-1-60","article-title":"ANCA-associated vasculitis","volume":"17","author":"Yates M","year":"2017","unstructured":"Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond). 2017, 17:60-4. 10.7861\/clinmedicine.17-1-60","journal-title":"Clin Med (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.006","article-title":"Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"12","author":"Sinico RA","year":"2013","unstructured":"Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013, 12:477-82. 10.1016\/j.autrev.2012.08.006","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2015.0043","article-title":"Updates in ANCA-associated vasculitis","volume":"3","author":"Pagnoux C","year":"2016","unstructured":"Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol. 2016, 3:122-33. 10.5152\/eurjrheum.2015.0043","journal-title":"Eur J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-32. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones RB","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, et al.. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363:211-20. 10.1056\/NEJMoa0909169","journal-title":"N Engl J Med"},{"key":"ref13","article-title":"Real world experience in ANCA-associated vasculitis (AAV) - a complex pathway of patient referral, diagnosis, and management","author":"Rutherford PA","year":"2018","unstructured":"Rutherford PA, Goette DK, Stamm M, Liu X. Real world experience in ANCA-associated vasculitis (AAV) - a complex pathway of patient referral, diagnosis, and management. ASN Kidney Week. American Society of Nephrology, Washington, DC, USA; 2018."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/403694-proteinase-3-antineutrophil-cytoplasmic-antibody-pr3-anca-associated-vasculitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T08:56:19Z","timestamp":1756976179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/403694-proteinase-3-antineutrophil-cytoplasmic-antibody-pr3-anca-associated-vasculitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.91582","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}